Schwab Charles Investment Management INC Cut Its Stake in Thermo Fisher Scientific INC (TMO) as Valuation Rose

April 17, 2018 - By Adrian Mccoy

Thermo Fisher Scientific Inc. (NYSE:TMO) LogoInvestors sentiment decreased to 0.91 in 2017 Q4. Its down 0.05, from 0.96 in 2017Q3. It fall, as 43 investors sold TMO shares while 410 reduced holdings. 93 funds opened positions while 319 raised stakes. 335.65 million shares or 0.74% more from 333.20 million shares in 2017Q3 were reported. Acg Wealth accumulated 16,810 shares. Mairs & holds 0% of its portfolio in Thermo Fisher Scientific Inc. (NYSE:TMO) for 1,460 shares. Tealwood Asset reported 11,150 shares. Whittier Trust accumulated 12,034 shares. Clean Yield Grp Inc invested in 4,568 shares or 0.34% of the stock. Cohen Cap Mngmt Inc accumulated 3.44% or 77,815 shares. Welch And Forbes Limited Liability Co invested 0.06% of its portfolio in Thermo Fisher Scientific Inc. (NYSE:TMO). Amer Natl Insur Tx reported 0.63% stake. Liberty Cap Mngmt has 19,469 shares for 2.16% of their portfolio. Amundi Pioneer Asset Management holds 0.64% of its portfolio in Thermo Fisher Scientific Inc. (NYSE:TMO) for 2.19M shares. First Long Island Ltd Liability Corp has invested 0.03% of its portfolio in Thermo Fisher Scientific Inc. (NYSE:TMO). Meag Munich Ergo Kapitalanlagegesellschaft Mbh invested in 0.44% or 59,667 shares. Barclays Pcl invested in 0.17% or 1.11M shares. Viking Fund Ltd Liability Corporation stated it has 8,500 shares or 0.26% of all its holdings. North Star Asset Inc invested 0.82% in Thermo Fisher Scientific Inc. (NYSE:TMO).

Since December 15, 2017, it had 0 buys, and 8 selling transactions for $37.14 million activity. Parrett William G sold $211,430 worth of Thermo Fisher Scientific Inc. (NYSE:TMO) on Friday, February 23. Williamson Stephen sold $1.05 million worth of stock or 5,000 shares. $7.32 million worth of Thermo Fisher Scientific Inc. (NYSE:TMO) shares were sold by Herrema Gregory J.. Shares for $1.31 million were sold by Durbin Patrick M.

Schwab Charles Investment Management Inc decreased its stake in Thermo Fisher Scientific Inc (TMO) by 2.68% based on its latest 2017Q4 regulatory filing with the SEC. Schwab Charles Investment Management Inc sold 42,085 shares as the company’s stock rose 8.51% while stock markets declined. The institutional investor held 1.53 million shares of the industrial machinery and components company at the end of 2017Q4, valued at $290.27 million, down from 1.57 million at the end of the previous reported quarter. Schwab Charles Investment Management Inc who had been investing in Thermo Fisher Scientific Inc for a number of months, seems to be less bullish one the $87.56 billion market cap company. The stock increased 0.80% or $1.7256 during the last trading session, reaching $217.6356. About 303,859 shares traded. Thermo Fisher Scientific Inc. (NYSE:TMO) has risen 33.66% since April 17, 2017 and is uptrending. It has outperformed by 22.11% the S&P500.

Schwab Charles Investment Management Inc, which manages about $126.11B US Long portfolio, upped its stake in Insperity Inc (NYSE:NSP) by 117,162 shares to 290,964 shares, valued at $16.69M in 2017Q4, according to the filing. It also increased its holding in Alphabet Inc by 26,196 shares in the quarter, for a total of 1.08M shares, and has risen its stake in V F Corp (NYSE:VFC).

Analysts await Thermo Fisher Scientific Inc. (NYSE:TMO) to report earnings on April, 25. They expect $2.40 EPS, up 15.38 % or $0.32 from last year’s $2.08 per share. TMO’s profit will be $965.57M for 22.67 P/E if the $2.40 EPS becomes a reality. After $2.79 actual EPS reported by Thermo Fisher Scientific Inc. for the previous quarter, Wall Street now forecasts -13.98 % negative EPS growth.

Thermo Fisher Scientific Inc. (NYSE:TMO) Ratings Coverage

Among 10 analysts covering Thermo Fisher (NYSE:TMO), 9 have Buy rating, 0 Sell and 1 Hold. Therefore 90% are positive. Thermo Fisher has $250 highest and $200.0 lowest target. $231.20’s average target is 6.23% above currents $217.6356 stock price. Thermo Fisher had 16 analyst reports since October 20, 2017 according to SRatingsIntel. The rating was maintained by Morgan Stanley with “Overweight” on Thursday, February 1. The firm earned “Overweight” rating on Thursday, February 1 by Barclays Capital. Jefferies maintained the stock with “Hold” rating in Friday, October 20 report. Robert W. Baird maintained the shares of TMO in report on Wednesday, January 31 with “Buy” rating. The company was maintained on Wednesday, October 25 by Cowen & Co. On Monday, October 23 the stock rating was maintained by Robert W. Baird with “Buy”. The stock of Thermo Fisher Scientific Inc. (NYSE:TMO) has “Buy” rating given on Monday, December 4 by Leerink Swann. The stock of Thermo Fisher Scientific Inc. (NYSE:TMO) has “Hold” rating given on Thursday, February 1 by Jefferies. The firm has “Overweight” rating given on Wednesday, April 11 by Morgan Stanley. As per Thursday, February 1, the company rating was maintained by Bank of America.

Thermo Fisher Scientific Inc. (NYSE:TMO) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.